Print PDF
Axinn Represents Charles River Laboratories in $585M Acquisition of WIL Research
January 11, 2016

Axinn is representing Charles River Laboratories International, Inc. in its $585 million acquisition of WIL Research, a premium provider of safety assessment and contract development and manufacturing (CDMO) services to biopharmaceutical and agricultural and industrial chemical companies. The Axinn team consists of John Harkrider, Mark Alexander, Jeny Maier and Kail Jethmalani.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.